NCT00111709已完成3 期
A Multicenter, Double-Blind, Randomized, Parallel-Group, Placebo Controlled Study to Evaluate the Efficacy and Tolerability of Rizatriptan 10 mg Tablets for the Treatment of Menstrual Migraine
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 393
- 主要终点
- Percentage of patients with 2 hour pain relief: 4-point headache severity scale as recorded in patient diary
研究概览
简要总结
The purpose of this study is to test the effectiveness of a marketed drug in the treatment of a menstrual migraine attack.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double (Participant, Investigator)
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •Female patient at least 18 years old
- •Patient has menses approximately monthly
- •Patient has at least a 5 month history of migraine and at least a 6 month history of menstrual migraine
排除标准
- •Pregnant and/or nursing
- •Cardiovascular disease
- •Uncontrolled hypertension
结局指标
主要结局
Percentage of patients with 2 hour pain relief: 4-point headache severity scale as recorded in patient diary
次要结局
- Percentage of patients with 24-hr sustained pain relief: headache severity between 2 and 24 hrs post dose as recorded in patient diary
研究者
相似试验
已完成
3 期
Study to Test a Marketed Drug in the Treatment of Menstrual Migraine (0462-072)MigraineNCT00111722Organon and Co393
已完成
3 期
Clinical Study Of Schizophrenia in Both Men and WomenSchizophreniaNCT00071747GlaxoSmithKline176
已完成
3 期
Efficacy and Safety Study for the Treatment of Dysfunctional Uterine BleedingMetrorrhagiaNCT00307801Bayer231
已完成
3 期
Efficacy and Safety Study for the Treatment of Dysfunctional Uterine BleedingMetrorrhagiaNCT00293059Bayer190
已完成
3 期
An Investigational Drug Study in Patients With Type 2 Diabetes Mellitus (MK0431-023)Diabetes Mellitus, Type 2NCT00094757Merck Sharp & Dohme LLC521